 |

|
 |
 |

 |
 |
Links
Guidelines
Journals
Articles
- Casalinuovo IA, Di Francesco P, Garaci E.
Fluconazole resistance in Candida albicans: a review of mechanisms.
Eur Rev Med Pharmacol Sci. 2004 Mar-Apr;8(2):69-77. Review.
- Cha R, Sobel JD.
Fluconazole for the treatment of candidiasis: 15 years experience.
Expert Rev Anti Infect Ther. 2004 Jun;2(3):357-66. Review.
- Chetchotisakd P, Sungkanuparph S, Thinkhamrop B, Mootsikapun P, Boonyaprawit P.
A multi-center, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency.
HIV Med. 2004 May;5(3):140-3.
- Dismukes WE
Cryptococcal meningitis in patients with AIDS.
J Infect Dis. 1988 Apr;157(4):624-8.
- Novelli V, Holzel H.
Safety and tolerability of fluconazole in children.
Antimicrob Agents Chemother. 1999 Aug;43(8):1955-60.
- Powderly WG, Saag MS, Cloud GA, Robinson P, Meyer RD, Jacobson JM, Graybill JR, Sugar AM, McAuliffe VJ, Follansbee SE, et al.
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
N Engl J Med. 1992 Mar 19;326(12):793-8.
|
|
|
|